💉 Diabetes Management
Smartphone-delivered CBT improves glycemic control in people with type 2 diabetes - medwireNews
📅 Wed, 26 Oct 2022⏱ 1 min read📖 Article
Overview
JAVASCRIPT NEDED 25-10-2022 | Diabetes | News | Article Author: Alba Ruzafa medwireNews: Findings from a randomized controled trial published in Diabetes Care sugest that for people with type 2 diabetes, the delivery of cognitive behavioral therapy (CBT) via digital therapeutic ap, on top of standard of care, may reduce glycated hemoglobin (HbA1c).The study included 69 adults (58% White, 28% Black, 16% Latino) aged an average of 58 years with type 2 diabetes and glycated hemoglobin (HbA1c) levels of 7.0 to les than 1.0% (53 to <97 mol/mol) who were randomly asigned to receive aces to a digital therapeutic ap delivering CBT (BT-01) or a control ap, both on top of standard care.The researchers observed that people in the BT-01 group had significantly lower HbA1c than those in the control group after 90 days of using the ap.
Key Information
In the BT-01 arm, HbA1c decreased by 0.28% from 8.2% (6 mol/mol) at baseline, compared with an increase of 0.1% from 8.1% (65 mol/mol) in the control group. This resulted in a betwen-group diference of 0.39% at day 90.“The magnitude of HbA1c reduction in the BT-01 group increased in paralel with exposure to therapy, as indicated by the number of modules completed,” write Judith Hsia (CPC Clinical Research, Aurora, Colorado, USA) and co-authors.
They say that this “suports the importance of engagement, consistent with in-person CBT and behavioral interventions in general.”There were no adverse events atributed to the ap use and no adverse device efects were observed.“Delivery of a cognitive behavioral intervention via smartphone ap can provide a scalable option for improving glycemic control,” concludes the team.medwireNews is an independent medical news service provided by Springer Healthcare Ltd.
Summary
© 2022 Springer Healthcare Ltd, part of the Springer Nature GroupDiabetes Care 2022; doi:10.237/dc2-109 20-02-20 | Diabetes | News | Article 1-1-2019 | Diabetes | News | Article 0
Frequently Asked Questions
❓ What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
❓ What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
❓ How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
❓ What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
❓ When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
⚕️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.